MetaStat expects to price public offering of 2,216,000 shares at $6.00

Company to grant bookrunner H.C. Wainwright 45-day greenshoe

By Devika Patel

Knoxville, Tenn., Nov. 18 – MetaStat, Inc. will sell 2,216,000 common shares in its public sale with a 45-day greenshoe of 300,000 additional shares, according to an S-1/A filed Wednesday with the Securities and Exchange Commission. The company has registered up to $13,804,717 of stock for the deal, which was announced on Oct. 13.

The shares will be sold at an expected price of $6.00 each.

H.C. Wainwright & Co., LLC is the bookrunner.

Proceeds will be used to continue clinical development and testing and for working capital and general corporate purposes.

MetaStat is a Boston-based molecular diagnostic company.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.